Kevin Ess
Concepts (336)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberous Sclerosis | 22 | 2025 | 56 | 4.700 |
Why?
| | Tumor Suppressor Proteins | 13 | 2023 | 330 | 3.120 |
Why?
| | Induced Pluripotent Stem Cells | 15 | 2025 | 272 | 1.760 |
Why?
| | TOR Serine-Threonine Kinases | 10 | 2023 | 441 | 1.430 |
Why?
| | Cellular Reprogramming | 2 | 2025 | 103 | 1.400 |
Why?
| | Sirolimus | 7 | 2024 | 278 | 1.030 |
Why?
| | Astrocytoma | 3 | 2021 | 130 | 1.000 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 3 | 2025 | 56 | 0.990 |
Why?
| | Neural Stem Cells | 7 | 2019 | 164 | 0.940 |
Why?
| | Tumor Suppressor Protein p53 | 5 | 2017 | 539 | 0.940 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 9 | 2025 | 138 | 0.890 |
Why?
| | Multiprotein Complexes | 4 | 2013 | 171 | 0.880 |
Why?
| | Neurons | 8 | 2020 | 1636 | 0.840 |
Why?
| | Hemiplegia | 3 | 2025 | 21 | 0.840 |
Why?
| | Cell Differentiation | 11 | 2025 | 2020 | 0.840 |
Why?
| | Brain | 9 | 2024 | 2892 | 0.820 |
Why?
| | Epilepsy | 5 | 2021 | 372 | 0.770 |
Why?
| | Signal Transduction | 14 | 2023 | 5214 | 0.770 |
Why?
| | Zebrafish | 6 | 2023 | 510 | 0.730 |
Why?
| | Fibroblasts | 2 | 2025 | 1044 | 0.730 |
Why?
| | Epilepsy, Generalized | 1 | 2021 | 19 | 0.700 |
Why?
| | Mosaicism | 1 | 2021 | 76 | 0.670 |
Why?
| | Skin | 1 | 2025 | 774 | 0.660 |
Why?
| | White Matter | 4 | 2017 | 146 | 0.640 |
Why?
| | Loss of Heterozygosity | 1 | 2017 | 51 | 0.540 |
Why?
| | Neurogenesis | 3 | 2017 | 154 | 0.510 |
Why?
| | Autistic Disorder | 1 | 2019 | 212 | 0.490 |
Why?
| | Heterozygote | 2 | 2017 | 311 | 0.490 |
Why?
| | Brain Neoplasms | 2 | 2021 | 1300 | 0.470 |
Why?
| | Autism Spectrum Disorder | 1 | 2021 | 425 | 0.470 |
Why?
| | Diffusion Tensor Imaging | 2 | 2015 | 75 | 0.460 |
Why?
| | Gene Deletion | 2 | 2013 | 394 | 0.420 |
Why?
| | Everolimus | 4 | 2025 | 111 | 0.420 |
Why?
| | Mutation | 9 | 2025 | 4053 | 0.410 |
Why?
| | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2013 | 2 | 0.410 |
Why?
| | Electron-Transferring Flavoproteins | 1 | 2013 | 4 | 0.400 |
Why?
| | Cell Culture Techniques | 3 | 2025 | 375 | 0.400 |
Why?
| | Zebrafish Proteins | 2 | 2013 | 298 | 0.390 |
Why?
| | Gene Knock-In Techniques | 1 | 2013 | 60 | 0.390 |
Why?
| | Carrier Proteins | 4 | 2015 | 752 | 0.390 |
Why?
| | Astrocytes | 5 | 2024 | 219 | 0.380 |
Why?
| | Mice, Knockout | 12 | 2019 | 3109 | 0.380 |
Why?
| | Regenerative Medicine | 1 | 2013 | 52 | 0.380 |
Why?
| | Kidney Tubules, Distal | 1 | 2012 | 5 | 0.380 |
Why?
| | Mitochondrial Diseases | 1 | 2013 | 94 | 0.370 |
Why?
| | Neuroglia | 2 | 2011 | 173 | 0.370 |
Why?
| | Gene Silencing | 1 | 2013 | 201 | 0.360 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2012 | 47 | 0.360 |
Why?
| | Disease Models, Animal | 13 | 2017 | 4522 | 0.360 |
Why?
| | Immunosuppressive Agents | 2 | 2019 | 859 | 0.360 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 4 | 2017 | 28 | 0.360 |
Why?
| | Stem Cell Transplantation | 1 | 2013 | 187 | 0.350 |
Why?
| | Animals | 35 | 2025 | 38010 | 0.350 |
Why?
| | Seizures | 4 | 2021 | 454 | 0.350 |
Why?
| | Corpus Callosum | 1 | 2012 | 72 | 0.350 |
Why?
| | Cells, Cultured | 8 | 2025 | 4182 | 0.340 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2015 | 471 | 0.340 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 341 | 0.330 |
Why?
| | Blood-Brain Barrier | 2 | 2024 | 150 | 0.330 |
Why?
| | Cilia | 1 | 2012 | 173 | 0.330 |
Why?
| | Myelin Sheath | 3 | 2017 | 166 | 0.330 |
Why?
| | Interneurons | 1 | 2011 | 124 | 0.330 |
Why?
| | Mice | 24 | 2025 | 18378 | 0.330 |
Why?
| | Codon, Nonsense | 1 | 2010 | 44 | 0.330 |
Why?
| | Nervous System Diseases | 1 | 2013 | 280 | 0.310 |
Why?
| | Humans | 48 | 2025 | 143560 | 0.310 |
Why?
| | Trans-Activators | 4 | 2012 | 402 | 0.300 |
Why?
| | Cerebral Cortex | 4 | 2020 | 464 | 0.300 |
Why?
| | Mutant Proteins | 2 | 2023 | 104 | 0.280 |
Why?
| | Alleles | 3 | 2017 | 893 | 0.260 |
Why?
| | Neurobiology | 1 | 2006 | 14 | 0.240 |
Why?
| | Child | 12 | 2025 | 22725 | 0.230 |
Why?
| | Carcinogenesis | 2 | 2019 | 232 | 0.230 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 3 | 2017 | 62 | 0.220 |
Why?
| | Huntington Disease | 2 | 2016 | 64 | 0.220 |
Why?
| | Electroencephalography | 2 | 2021 | 531 | 0.210 |
Why?
| | Proto-Oncogene Proteins | 3 | 1999 | 626 | 0.210 |
Why?
| | Proteins | 4 | 2015 | 1022 | 0.200 |
Why?
| | Transcription Factors | 4 | 2012 | 1754 | 0.190 |
Why?
| | Arrhythmias, Cardiac | 1 | 2025 | 348 | 0.180 |
Why?
| | Biopsy | 1 | 2025 | 1083 | 0.180 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2014 | 187 | 0.180 |
Why?
| | Fatty Acids | 1 | 2025 | 452 | 0.180 |
Why?
| | Embryonic and Fetal Development | 2 | 1999 | 94 | 0.180 |
Why?
| | Female | 17 | 2025 | 77252 | 0.170 |
Why?
| | Oncogenes | 2 | 1999 | 119 | 0.170 |
Why?
| | Thymus Gland | 3 | 1999 | 319 | 0.170 |
Why?
| | Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 3 | 0.170 |
Why?
| | Male | 15 | 2025 | 71501 | 0.170 |
Why?
| | Mitochondria | 4 | 2015 | 988 | 0.160 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1794 | 0.160 |
Why?
| | GTPase-Activating Proteins | 1 | 2020 | 85 | 0.160 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2023 | 340 | 0.160 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 1 | 2019 | 22 | 0.160 |
Why?
| | DNA Methylation | 1 | 2025 | 667 | 0.160 |
Why?
| | Endothelial Cells | 3 | 2025 | 846 | 0.150 |
Why?
| | Immunization | 1 | 2021 | 404 | 0.150 |
Why?
| | Lateral Ventricles | 1 | 2019 | 32 | 0.150 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2017 | 894 | 0.150 |
Why?
| | Polycystic Kidney Diseases | 1 | 2019 | 73 | 0.140 |
Why?
| | Aquaporin 4 | 1 | 2019 | 100 | 0.140 |
Why?
| | Drug Resistant Epilepsy | 1 | 2020 | 116 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 346 | 0.140 |
Why?
| | Recurrence | 1 | 2021 | 1114 | 0.140 |
Why?
| | Manganese | 2 | 2014 | 56 | 0.140 |
Why?
| | Wnt Signaling Pathway | 2 | 2023 | 213 | 0.130 |
Why?
| | Genes, p53 | 1 | 2017 | 68 | 0.130 |
Why?
| | Membrane Potentials | 1 | 2018 | 280 | 0.130 |
Why?
| | Parkinson Disease | 2 | 2014 | 576 | 0.130 |
Why?
| | Fibrosis | 1 | 2019 | 545 | 0.130 |
Why?
| | Practice Guidelines as Topic | 2 | 2021 | 1557 | 0.120 |
Why?
| | Demyelinating Diseases | 1 | 2016 | 83 | 0.120 |
Why?
| | Phenotype | 3 | 2020 | 3211 | 0.120 |
Why?
| | Myocytes, Cardiac | 2 | 2023 | 546 | 0.120 |
Why?
| | Child, Preschool | 7 | 2025 | 11737 | 0.120 |
Why?
| | Central Nervous System | 1 | 2017 | 269 | 0.120 |
Why?
| | Genomic Instability | 1 | 2016 | 61 | 0.120 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 637 | 0.110 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 336 | 0.110 |
Why?
| | Infant | 6 | 2018 | 9981 | 0.110 |
Why?
| | Polyesters | 1 | 2015 | 79 | 0.110 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 73 | 0.110 |
Why?
| | Cell Line | 6 | 2015 | 2897 | 0.110 |
Why?
| | Neuroimaging | 1 | 2016 | 282 | 0.110 |
Why?
| | Cadmium | 1 | 2014 | 68 | 0.110 |
Why?
| | Flow Cytometry | 2 | 2024 | 1192 | 0.110 |
Why?
| | Protein Structure, Tertiary | 2 | 2015 | 863 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 1995 | 174 | 0.110 |
Why?
| | Chromatin | 2 | 2015 | 554 | 0.110 |
Why?
| | Enhancer Elements, Genetic | 1 | 1995 | 194 | 0.110 |
Why?
| | Copper | 1 | 2014 | 115 | 0.100 |
Why?
| | RNA, Messenger | 3 | 2020 | 2852 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 2 | 2016 | 3798 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2015 | 167 | 0.100 |
Why?
| | Checklist | 1 | 2014 | 106 | 0.100 |
Why?
| | Glutamic Acid | 2 | 2007 | 259 | 0.100 |
Why?
| | Pluripotent Stem Cells | 1 | 2014 | 81 | 0.100 |
Why?
| | Brain Diseases | 1 | 2014 | 151 | 0.100 |
Why?
| | Founder Effect | 1 | 2013 | 12 | 0.100 |
Why?
| | Neoplasm Invasiveness | 1 | 1995 | 518 | 0.100 |
Why?
| | Models, Theoretical | 1 | 2016 | 586 | 0.100 |
Why?
| | Manganese Poisoning | 1 | 2012 | 1 | 0.100 |
Why?
| | Corpus Striatum | 1 | 2014 | 180 | 0.100 |
Why?
| | Abdominal Neoplasms | 1 | 2013 | 47 | 0.100 |
Why?
| | Parkinson Disease, Secondary | 1 | 2012 | 8 | 0.100 |
Why?
| | Stem Cells | 3 | 2023 | 619 | 0.090 |
Why?
| | Homozygote | 1 | 2013 | 201 | 0.090 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2013 | 60 | 0.090 |
Why?
| | Adolescent | 7 | 2025 | 22482 | 0.090 |
Why?
| | Paired Box Transcription Factors | 1 | 2012 | 43 | 0.090 |
Why?
| | Genetic Testing | 1 | 2015 | 474 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 266 | 0.090 |
Why?
| | Chlorides | 1 | 2012 | 137 | 0.090 |
Why?
| | Exons | 1 | 2013 | 359 | 0.090 |
Why?
| | Blotting, Western | 2 | 2012 | 1223 | 0.090 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 383 | 0.090 |
Why?
| | Eye Proteins | 1 | 2012 | 92 | 0.090 |
Why?
| | Blood Vessels | 1 | 2013 | 175 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 190 | 0.090 |
Why?
| | SOXB1 Transcription Factors | 1 | 2012 | 66 | 0.090 |
Why?
| | Mice, Transgenic | 2 | 2013 | 2194 | 0.090 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 295 | 0.090 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2012 | 141 | 0.090 |
Why?
| | Glioblastoma | 1 | 1995 | 350 | 0.090 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 191 | 0.080 |
Why?
| | Quinolines | 1 | 2012 | 171 | 0.080 |
Why?
| | Cognition | 1 | 2019 | 1261 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 441 | 0.080 |
Why?
| | Cell Lineage | 2 | 2019 | 368 | 0.080 |
Why?
| | Cell Size | 1 | 2010 | 91 | 0.080 |
Why?
| | Lung | 1 | 2023 | 4101 | 0.080 |
Why?
| | Environmental Pollutants | 1 | 2012 | 165 | 0.080 |
Why?
| | Autophagy | 1 | 2013 | 287 | 0.080 |
Why?
| | Liver | 3 | 2015 | 1864 | 0.080 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 550 | 0.080 |
Why?
| | Polyethylene Glycols | 1 | 2015 | 642 | 0.080 |
Why?
| | Embryo, Nonmammalian | 1 | 2010 | 168 | 0.080 |
Why?
| | Molecular Targeted Therapy | 1 | 2013 | 431 | 0.080 |
Why?
| | Genetic Markers | 2 | 2005 | 345 | 0.080 |
Why?
| | Up-Regulation | 1 | 2013 | 863 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2017 | 2542 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2011 | 201 | 0.080 |
Why?
| | Cell Death | 1 | 2011 | 394 | 0.080 |
Why?
| | Biomedical Research | 1 | 2016 | 699 | 0.080 |
Why?
| | Hepatocytes | 1 | 2010 | 219 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-myb | 3 | 1999 | 10 | 0.070 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2621 | 0.070 |
Why?
| | Spinal Cord Injuries | 1 | 2013 | 238 | 0.070 |
Why?
| | Behavior, Animal | 1 | 2012 | 516 | 0.070 |
Why?
| | Cell Cycle Proteins | 1 | 2013 | 651 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 438 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1062 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2012 | 412 | 0.070 |
Why?
| | Pyrazoles | 1 | 2012 | 496 | 0.070 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 523 | 0.070 |
Why?
| | Aging | 2 | 2023 | 1946 | 0.070 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2007 | 112 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1736 | 0.070 |
Why?
| | Adult | 7 | 2021 | 40012 | 0.060 |
Why?
| | Protein Biosynthesis | 2 | 2013 | 453 | 0.060 |
Why?
| | DNA | 2 | 2012 | 1457 | 0.060 |
Why?
| | Karyotyping | 2 | 2016 | 106 | 0.060 |
Why?
| | Mental Disorders | 1 | 2014 | 1151 | 0.060 |
Why?
| | Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.060 |
Why?
| | Sleep | 1 | 2012 | 889 | 0.060 |
Why?
| | Synaptic Transmission | 1 | 2007 | 295 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2010 | 1043 | 0.060 |
Why?
| | Anxiety | 1 | 2012 | 1090 | 0.060 |
Why?
| | Neuronal Plasticity | 1 | 2007 | 305 | 0.050 |
Why?
| | Amino Acid Motifs | 2 | 2015 | 226 | 0.050 |
Why?
| | Death, Sudden, Cardiac | 1 | 2025 | 194 | 0.050 |
Why?
| | Membrane Potential, Mitochondrial | 2 | 2014 | 74 | 0.050 |
Why?
| | Mice, Nude | 2 | 2015 | 710 | 0.050 |
Why?
| | Centrosome | 1 | 2023 | 73 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1957 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2942 | 0.050 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2002 | 27 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2025 | 3625 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 682 | 0.050 |
Why?
| | DNA Damage | 2 | 2016 | 446 | 0.050 |
Why?
| | Binding Sites | 2 | 2015 | 1325 | 0.050 |
Why?
| | Electrocardiography | 1 | 2025 | 630 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 607 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 3 | 2015 | 2417 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 139 | 0.040 |
Why?
| | Drug Approval | 1 | 2021 | 89 | 0.040 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2021 | 80 | 0.040 |
Why?
| | Malformations of Cortical Development | 1 | 2020 | 14 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 732 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2020 | 55 | 0.040 |
Why?
| | Stroke Volume | 1 | 2023 | 607 | 0.040 |
Why?
| | Advisory Committees | 1 | 2021 | 215 | 0.040 |
Why?
| | Seizures, Febrile | 1 | 2019 | 22 | 0.040 |
Why?
| | Genetic Variation | 1 | 2025 | 1008 | 0.040 |
Why?
| | Patient Advocacy | 1 | 2020 | 75 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2023 | 520 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2019 | 32 | 0.040 |
Why?
| | Cell Survival | 2 | 2013 | 1136 | 0.040 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Odontogenesis | 1 | 1999 | 11 | 0.040 |
Why?
| | Digestive System | 1 | 1999 | 28 | 0.040 |
Why?
| | Culture Media | 1 | 2019 | 165 | 0.040 |
Why?
| | Hair Follicle | 1 | 1999 | 48 | 0.040 |
Why?
| | Kidney Tubules, Proximal | 1 | 2019 | 128 | 0.040 |
Why?
| | Tamoxifen | 1 | 2019 | 204 | 0.040 |
Why?
| | Adenosine Deaminase | 2 | 1996 | 44 | 0.040 |
Why?
| | Thyroid Gland | 1 | 1999 | 93 | 0.040 |
Why?
| | In Situ Hybridization | 1 | 1999 | 321 | 0.040 |
Why?
| | Machine Learning | 1 | 2024 | 574 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1831 | 0.030 |
Why?
| | Myofibroblasts | 1 | 2019 | 136 | 0.030 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2018 | 47 | 0.030 |
Why?
| | Mitosis | 1 | 1999 | 202 | 0.030 |
Why?
| | Oligodendrocyte Precursor Cells | 1 | 2017 | 23 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2018 | 249 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2019 | 354 | 0.030 |
Why?
| | Trachea | 1 | 1999 | 250 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3611 | 0.030 |
Why?
| | Strategic Planning | 1 | 2016 | 3 | 0.030 |
Why?
| | Zinostatin | 1 | 2016 | 1 | 0.030 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2016 | 16 | 0.030 |
Why?
| | Myosin Light Chains | 1 | 2015 | 28 | 0.030 |
Why?
| | Ethylnitrosourea | 1 | 2015 | 13 | 0.030 |
Why?
| | Fluorescence Polarization | 1 | 2015 | 24 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 121 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1995 | 49 | 0.030 |
Why?
| | Genetic Complementation Test | 1 | 1995 | 66 | 0.030 |
Why?
| | Two-Hybrid System Techniques | 1 | 2015 | 58 | 0.030 |
Why?
| | Base Sequence | 2 | 1996 | 2199 | 0.030 |
Why?
| | Anisotropy | 1 | 2015 | 77 | 0.030 |
Why?
| | Methylmercury Compounds | 1 | 2014 | 9 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2015 | 150 | 0.030 |
Why?
| | Troponin I | 1 | 2015 | 72 | 0.030 |
Why?
| | Point Mutation | 1 | 1995 | 243 | 0.030 |
Why?
| | Introns | 1 | 1995 | 255 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1877 | 0.030 |
Why?
| | Goals | 1 | 2016 | 182 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 346 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 397 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 300 | 0.030 |
Why?
| | Axons | 1 | 2015 | 199 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 404 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 198 | 0.030 |
Why?
| | Genes, Lethal | 1 | 2013 | 30 | 0.020 |
Why?
| | HeLa Cells | 1 | 1995 | 650 | 0.020 |
Why?
| | RNA, Ribosomal, 18S | 1 | 2013 | 27 | 0.020 |
Why?
| | Manganese Compounds | 1 | 2012 | 2 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 447 | 0.020 |
Why?
| | United States | 3 | 2021 | 15554 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2014 | 250 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2012 | 127 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2015 | 748 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2936 | 0.020 |
Why?
| | PAX6 Transcription Factor | 1 | 2012 | 21 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1984 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2015 | 867 | 0.020 |
Why?
| | Homeostasis | 2 | 2007 | 641 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2014 | 325 | 0.020 |
Why?
| | Age Factors | 1 | 1999 | 3328 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 1995 | 556 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2165 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2012 | 176 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2012 | 143 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1781 | 0.020 |
Why?
| | Young Adult | 2 | 2018 | 13972 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 7153 | 0.020 |
Why?
| | Models, Molecular | 1 | 2015 | 1622 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 642 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 35343 | 0.020 |
Why?
| | Risk Factors | 2 | 2014 | 10644 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1838 | 0.020 |
Why?
| | Protein Binding | 1 | 2015 | 2261 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2056 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 6043 | 0.020 |
Why?
| | Nerve Degeneration | 1 | 2007 | 49 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6366 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2007 | 106 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3380 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 157 | 0.020 |
Why?
| | Neocortex | 1 | 2007 | 44 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1995 | 2026 | 0.020 |
Why?
| | Long-Term Potentiation | 1 | 2007 | 200 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 2003 | 70 | 0.010 |
Why?
| | Gliosis | 1 | 2003 | 29 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 11365 | 0.010 |
Why?
| | Electrophysiology | 1 | 2003 | 220 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2002 | 206 | 0.010 |
Why?
| | Hippocampus | 1 | 2007 | 948 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 7032 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 16740 | 0.010 |
Why?
| | Synapses | 1 | 2003 | 436 | 0.010 |
Why?
| | Aged | 1 | 2016 | 25322 | 0.010 |
Why?
| | Awards and Prizes | 1 | 1996 | 72 | 0.010 |
Why?
| | Hematopoiesis | 1 | 1996 | 194 | 0.010 |
Why?
| | Societies, Medical | 1 | 1996 | 873 | 0.010 |
Why?
| | Biomarkers | 1 | 2002 | 4241 | 0.010 |
Why?
|
|
Ess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|